NeoGenomics names Vishal Sikri President of Inivata; Dr. Clive Morris retiring in June

NEOGENOMICS INC

Vishal Sikri appointed President and CCO of Inivata, effective May 23, 2022.
Dr. Clive Morris to retire as President of Inivata effective June 30, 2022; settlement terms not yet determined.
Dr. Gina Wallar, President of Pharma Services Division, resigning effective May 27, 2022; Jennifer Rose interim.
Sikri receives base salary $510K, annual bonus target 50% of salary, sign-on bonus $500K, and equity grant $1.055M.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Clive D. Morris

President of Inivata

NEO · NEOGENOMICS INC

Effective: 2022-06-30
Successor: Vishal Sikri
Filed: May 11, 2022, 7:59 PM ET

On May 5, 2022, Dr. Clive D. Morris, NeoGenomics, Inc.’s (the “Company”) current President of Inivata, informed the Company of his intention to retire from his role effective June 30, 2022.

Appointed

Vishal Sikri

President and Chief Commercial Officer, Inivata Division

NEO · NEOGENOMICS INC

Effective: 2022-05-23
Filed: May 11, 2022, 7:59 PM ET

On May 9, 2022, the Company announced that Vishal Sikri, age 46, was appointed President and Chief Commercial Officer, Inivata Division, of the Company, effective May 23, 2022 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Clive D. Morris departed as President of Inivata at NEOGENOMICS INC.

Action: retire
Role: President of Inivata

Exact text from the filing

On May 5, 2022, Dr. Clive D. Morris, NeoGenomics, Inc.’s (the “Company”) current President of Inivata, informed the Company of his intention to retire from his role effective June 30, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Vishal Sikri was appointed as President and Chief Commercial Officer, Inivata Division at NEOGENOMICS INC.

Action: appointed
Role: President and Chief Commercial Officer, Inivata Division

Exact text from the filing

On May 9, 2022, the Company announced that Vishal Sikri, age 46, was appointed President and Chief Commercial Officer, Inivata Division, of the Company, effective May 23, 2022 (the “Effective Date”).

View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-22-000083

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.